Resultados globales: 11 registros encontrados en 0.02 segundos.
Artículos, Encontrados 8 registros
Documentos de investigación, Encontrados 2 registros
Materiales académicos, Encontrados 1 registros
Artículos Encontrados 8 registros  
1.
9 p, 1.4 MB Predictive signature of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer integrating mRNA expression, taxonomic subtypes, and clinicopathological features / Font, Albert (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Domenech, Montserrat (Althaia Xarxa Assistencial Universitària de Manresa) ; Ramirez, Jose Luis (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Marqués, Miriam (Centro Nacional de Investigaciones Oncológicas) ; Benítez, Raquel (Centro Nacional de Investigaciones Oncológicas) ; Ruiz de Porras, Vicenç (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Gago, José L. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Carrato, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Sant, Francesc (Althaia Xarxa Assistencial Universitària de Manresa) ; Lopez, Hector (Althaia Xarxa Assistencial Universitària de Manresa) ; Castellano, Daniel (Hospital Universitario 12 de Octubre (Madrid)) ; Malats, Nuria (Centro Nacional de Investigaciones Oncológicas) ; Calle, M. Luz (Universitat de Vic - Universitat Central de Catalunya) ; Real, Francisco X. (Universitat Pompeu Fabra)
Background and objective: Neoadjuvant chemotherapy (NAC) followed by cystectomy is the standard of care in muscle-invasive bladder cancer (MIBC). Pathological response has been associated with longer survival, but no currently available clinicopathological variables can identify patients likely to respond, highlighting the need for predictive biomarkers. [...]
2023 - 10.3389/fonc.2023.1155244
Frontiers in Oncology, Vol. 13 (august 2023)  
2.
8 p, 808.0 KB Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guérin immunotherapy for T1G3/HG bladder cancer / D'Andrea, David (Department of Urology. Comprehensive Cancer Center. Medical University of Vienna) ; Soria, F. (Division of Urology. University of the Studies of Turin. AOU Città Della Salute e Della Scienza di Torino) ; Grotenhuis, A.J. (Radboud University Medical Centre. Department of Urology) ; Cha, E.K. (Department of Urology. Memorial Sloan Kettering Cancer Center) ; Malats, Núria (Centro Nacional de Investigaciones Oncológicas) ; Di Stasi, S. (Department of Urology. Policlinico Tor Vergata-University of Rome) ; Joniau, Steven (Oncologic and Reconstructive Urology. Department of Urology. University Hospitals Leuven) ; Cai, T. (Department of Urology. Santa Chiara Hospital) ; van Rhijn, B.W.G. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ; Irani, J. (Department of Urology. Centre Hospitalier Universitaire La Milétrie. University of Poitiers) ; Karnes, J. (Department of Urology. Mayo Clinic) ; Varkarakis, J. (Department of Urology. Sismanoglio Hospital. University of Athens) ; Baniel, J. (Department of Urology. Rabin Medical Centre) ; Palou, Juan (Institut d'Investigació Biomèdica Sant Pau) ; Babjuk, Marek (Department of Urology. Motol Hospital. University of Praha) ; Spahn, M. (Department of Urology. University Hospital of Wuerzburg) ; Ardelt, P. (Department of Urology. Universitätsklinik Freiburg) ; Colombo, Renzo (Departement of Urology. Università Vita Salute. Ospedale S. Raffaele) ; Serretta, V. (Department of Surgical. Oncological and Stomatological Sciences. University of Palermo) ; Dalbagni, G. (Department of Urology. Memorial Sloan Kettering Cancer Center) ; Gontero, P. (Division of Urology. University of the Studies of Turin. AOU Città Della Salute e Della Scienza di Torino) ; Bartoletti, R. (Department of Translational Research and New Technologies. University of Pisa) ; Larré, S. (Department of Urology. CHU de Reims) ; Malmstrom, P.U. (Department of Urology. Academic Hospital. Uppsala University) ; Sylvester, R. (European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel) ; Shariat, S.F. (European Association of Urology Research Foundation)
Purpose: To investigate the association of patients' sex with recurrence and disease progression in patients treated with intravesical bacillus Calmette-Guérin (BCG) for T1G3/HG urinary bladder cancer (UBC). [...]
2021 - 10.1007/s00345-021-03653-1
World Journal of Urology, Vol. 39 Núm. 9 (september 2021) , p. 3337-3344  
3.
7 p, 485.9 KB Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer : An International Validation in Primary Tumours / Vedder, Moniek M. (Erasmus Medical Centre, Rotterdam, the Netherlands) ; Márquez, Mirari (Centro Nacional de Investigaciones Oncológicas Carlos III (Espanya)) ; de Bekker-Grob, Esther W. (Erasmus Medical Centre, Rotterdam, the Netherlands) ; Calle, M. Luz (Universitat de Vic - Universitat Central de Catalunya) ; Dyrskjøt, Lars (Aalborg University Hospital (Dinamarca)) ; Kogevinas, Manoils (Centre de Recerca en Epidemiologia Ambiental) ; Segersten, Ulrika (Uppsala University, Uppsala, Sweden) ; Malmström, Per-Uno (Uppsala University, Uppsala, Sweden) ; Algaba, Ferran (Institut d'Investigació Biomèdica Sant Pau) ; Beukers, Willemien (Erasmus Medical Centre, Rotterdam, the Netherlands) ; Ørntoft, Torben F. (Aalborg University Hospital (Dinamarca)) ; Zwarthoff, Ellen (Erasmus Medical Centre, Rotterdam, the Netherlands) ; Real, Francisco X. (Universitat Pompeu Fabra) ; Malats, Núria (Centro Nacional de Investigaciones Oncológicas Carlos III (Espanya)) ; Steyerberg, Ewout W. (Erasmus Medical Centre, Rotterdam, the Netherlands) ; Universitat Autònoma de Barcelona
We aimed to determine the validity of two risk scores for patients with non-muscle invasive bladder cancer in different European settings, in patients with primary tumours. We included 1,892 patients with primary stage Ta or T1 non-muscle invasive bladder cancer who underwent a transurethral resection in Spain (n = 973), the Netherlands (n = 639), or Denmark (n = 280). [...]
2014 - 10.1371/journal.pone.0096849
PloS one, Vol. 9 (june 2014)  
4.
11 p, 1.8 MB Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer / Klein, Alison P. (Johns Hopkins School of Medicine, Baltimore, USA) ; Wolpin, Brian M. (Dana-Farber Cancer Institute, Boston, USA) ; Risch, Harvey A. (Yale School of Public Health, New Haven, USA) ; Stolzenberg-Solomon, Rachael Z. (National Institutes of Health, Bethesda, USA) ; Mocci, Evelina (Johns Hopkins School of Medicine, Baltimore, USA) ; Zhang, Mingfeng (National Cancer Institute, National Institutes of Health, Bethesda, USA) ; Canzian, Federico (Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany) ; Childs, Erica J. (Johns Hopkins School of Medicine, Baltimore, USA) ; Hoskins, Jason W. (National Cancer Institute, National Institutes of Health, Bethesda, USA) ; Jermusyk, Ashley (National Cancer Institute, National Institutes of Health, Bethesda, USA) ; Zhong, Jun (National Cancer Institute, National Institutes of Health, Bethesda, USA) ; Chen, Fei (Johns Hopkins School of Medicine, Baltimore, USA) ; Albanes, Demetrius (National Cancer Institute, National Institutes of Health, Bethesda, USA) ; Andreotti, Gabriella (National Institutes of Health, Bethesda, USA) ; Arslan, Alan A. (New York University School of Medicine, New York, USA) ; Babic, Ana (Dana-Farber Cancer Institute, Boston, USA) ; Bamlet, William R. (Mayo Clinic College of Medicine, Rochester, USA) ; Beane-Freeman, Laura (National Cancer Institute, National Institutes of Health, Bethesda, USA) ; Berndt, Sonja (National Institutes of Health, Bethesda, USA) ; Blackford, Amanda (Johns Hopkins School of Medicine, Baltimore, USA) ; Borges, Michael (Johns Hopkins School of Medicine, Baltimore, USA) ; Borgida, Ayelet (Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, M5G 1×5, Canada.) ; Bracci, Paige M. (University of California, San Francisco, USA) ; Brais, Lauren (Dana-Farber Cancer Institute, Boston, USA) ; Brennan, Paul (International Agency for Research on Cancer (IARC), Lyon, France) ; Brenner, Hermann (Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany) ; Bueno-de-Mesquita, Bas (National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands) ; Buring, Julie (Division of Preventive Medicine, Brigham and Women's Hospital, Boston) ; Campa, Daniele (University of Pisa) ; Capurso, Gabriele (University of Rome) ; Cavestro, Giulia Martina (Vita-Salute San Raffaele University, Milan) ; Chaffee, Kari G (Mayo Clinic College of Medicine, Rochester, USA) ; Chung, Charles C. (National Institutes of Health, Bethesda, USA) ; Cleary, Sean (Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada) ; Cotterchio, Michelle (University of Toronto.) ; Dijk, Frederike (University of Amsterdam. Department of Pathology, Academic Medical Center) ; Duell, Eric J. (Institut d'Investigació Biomèdica de Bellvitge) ; Foretova, Lenka (Masaryk Memorial Cancer Institute. Department of Cancer Epidemiology and Genetics, Brno, Czech Republic.) ; Fuchs, Charles (Yale Cancer Center, New Haven, USA) ; Funel, Niccola (University of Pisa.) ; Gallinger, Steven (Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada) ; M. Gaziano, J. Michael (Boston VA Healthcare System) ; Gazouli, Maria (National and Kapodistrian University of Athens) ; Giles, Graham G. (Monash University. Department of Epidemiology and Preventive Medicine, Melbourne, Australia) ; Giovannucci, Edward (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Goggins, Michael (Johns Hopkins School of Medicine. Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Baltimore) ; Goodman, Gary E. (Fred Hutchinson Cancer Research Center. Division of Public Health Sciences, Seattle, USA) ; Goodman, Phyllis J. (Fred Hutchinson Cancer Research Center. SWOG Statistical Center, Seattle, USA) ; Hackert, Thilo (University Hospital Heidelberg, Germany) ; Haiman, Christopher A (University of Southern California, USA) ; Hartge, Patricia (National Institutes of Health, Bethesda, USA) ; Hasan, Manal (University of Texas MD Anderson Cancer Center, USA) ; Hegyi, Peter (University of Szeged, Szeged, Hungary) ; Helzlsouer, Kathy J. (National Institutes of Health, Bethesda, USA) ; Herman, Joseph (Johns Hopkins School of Medicine. Baltimore, USA) ; Holcatova, Ivana (Charles University, Prague, Czech Republic) ; Holly, Elizabeth A. (University of California, San Francisco) ; Hoover, Robert (National Institutes of Health, Bethesda, USA) ; Hung, Rayjean J. (Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada) ; Jacobs, Eric J. (American Cancer Society. Epidemiology Research Program, Atlanta) ; Jamroziak, Krzysztof (Institute of Hematology and Transfusion Medicine, Warsaw, Poland) ; Janout, Vladimir (Faculty of Medicine, University of Olomouc, Czech Republic) ; Kaaks, Rudolf (German Cancer Research Center (DKFZ), Heidelberg, Germany) ; Khaw, Kay-Tee (University of Cambridge) ; Klein, Eric A. (Cleveland Clinic) ; Kogevinas, M (Hospital del Mar (Barcelona, Catalunya)) ; Kooperberg, Charles (Fred Hutchinson Cancer Research Center, Seattle) ; Kulke, Matthew H. (Dana-Farber Cancer Institute, Boston) ; Kupcinskas, Juozas (Lithuanian University of Health Sciences, Kaunas, Lithuania) ; Kurtz, Robert J. (Memorial Sloan Kettering Cancer Center, New York, USA) ; Laheru, Daniel (Johns Hopkins School of Medicine, Baltimore, USA) ; Landi, Stefano (University of Pisa) ; Lawlor, Rita T. (University and Hospital Trust of Verona) ; Lee, I.-Min (Harvard School of Public Health, Boston) ; LeMarchand, Loic (University of Hawaii Cancer Center, Honolulu, USA) ; Lu, Lingeng (Yale School of Public Health, New Haven, USA) ; Malats, Núria (Centro de Investigación Biomédica en Red de Cáncer, Madrid) ; Mambrini, Andrea (Oncology Department, ASL1 Massa Carrara, Italy) ; Mannisto, Satu (National Institute for Health and Welfare, Helsinki, Finland) ; Milne, Roger L. (The University of Melbourne, Australia) ; Mohelníková-Duchoňová, Beatrice (Palacky University Olomouc and University Hospital, Czech Republic) ; Neale, Rachel E. (QIMR Berghofer Medical Research Institute (Brisbane, Austràlia)) ; Neoptolemos, John P. (University of Heidelburg, Heidelberg, Germany) ; Oberg, Ann L. (Mayo Clinic College of Medicine, Rochester, USA) ; Olson, Sara H. (Memorial Sloan Kettering Cancer Center, New York, USA) ; Orlow, Irene (Memorial Sloan Kettering Cancer Center, New York, USA) ; Pasquali, Claudio (University of Padua, Italy) ; Patel, Alpa V. (American Cancer Society, Atlanta) ; Peters, Ulrike (Fred Hutchinson Cancer Research Center, Seattle) ; Pezzilli, Raffaele (Sant'Orsola-Malpighi Hospital, Bologna, Italy) ; Porta, Miquel 1957- (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ; Real, Francisco X. (Universitat Pompeu Fabra) ; Rothman, Nathaniel (National Institutes of Health, Bethesda, USA) ; Scelo, Ghislaine (International Agency for Research on Cancer (IARC), Lyon, France) ; Sesso, Howard D. (Harvard T.H. Chan School of Public Health. Department of Epidemiology) ; Severi, Gianluca (Université Paris-Saclay, France) ; Shu, Xiao-Ou (Vanderbilt University School of Medicine, Nashville, USA) ; Silverman, Debra (National Institutes of Health, Bethesda, USA) ; Smith, Jill P. (Georgetown University, Washington, USA) ; Soucek, Pavel (Charles University, Pilsen, Czech Republic.) ; Sund, Malin (Umeå University, Sweden) ; Talar-Wojnarowska, Renata (Medical University of Łodz, Poland) ; Tavano, Francesca (Istituto di Ricovero e Cura A Carattere Scientifico (IRCCS), Italy) ; Thornquist, Mark D. (Fred Hutchinson Cancer Research Center, Seattle) ; Tobias, Geoffrey S. (National Institutes of Health, Bethesda, USA) ; Van Den Eeden, Stephen K. (Kaiser Permanente Northern California, USA) ; Vashist, Yogesh (University Hamburg-Eppendorf, Germany) ; Visvanathan, Kala (Johns Hopkins Bloomberg School of Public Health, Baltimore, USA) ; Vodicka, Pavel (Academy of Sciences of the Czech Republic, Prague, Czech Republic) ; Wactawski-Wende, Jean (University at Buffalo, USA) ; Wang, Zhaoming (St. Jude Children's Research Hospital (Memphis, Estats Units d'Amèrica)) ; Wentzensen, Nicolas (National Cancer Institute, National Institutes of Health, Bethesda, USA) ; White, Emily (University of Washington, USA) ; Yu, Herbert (University of Hawaii Cancer Center, USA) ; Yu, Kai (National Institutes of Health, Bethesda, USA) ; Zeleniuch-Jacquotte, Anne (New York University School of Medicine, USA) ; Zheng, Wei (Vanderbilt University School of Medicine, Nashville, USA) ; Kraft, Peter (Harvard School of Public Health, USA) ; Li, Donghui (University of Texas MD Anderson Cancer Center, USA) ; Chanock, Stephen (National Institutes of Health, Bethesda, USA) ; Obazee, Ofure (German Cancer Research Center (DKFZ), Heidelberg, Germany) ; Petersen, Gloria M. (Mayo Clinic College of Medicine, Rochester, USA) ; Amundadottir, Laufey T. (National Cancer Institute (Bethesda, Estats Units d'Amèrica))
In 2020, 146,063 deaths due to pancreatic cancer are estimated to occur in Europe and the United States combined. To identify common susceptibility alleles, we performed the largest pancreatic cancer GWAS to date, including 9040 patients and 12,496 controls of European ancestry from the Pancreatic Cancer Cohort Consortium (PanScan) and the Pancreatic Cancer Case-Control Consortium (PanC4). [...]
2018 - 10.1038/s41467-018-02942-5
Nature communications, Vol. 9 (february 2018)  
5.
13 p, 1.1 MB Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant Chemotherapy / Font, Albert (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Domènech, Montserrat (Medical Oncology Department, Fundació Althaia, 08243 Manresa, Spain) ; Benítez, Raquel (Centro Nacional de Investigaciones Oncológicas) ; Rava, Marta (Centro Nacional de Investigaciones Oncológicas) ; Marqués, Miriam (Centro Nacional de Investigaciones Oncológicas) ; Ramirez, Jose Luis (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Pineda, Silvia (Centro Nacional de Investigaciones Oncológicas) ; Domínguez-Rodríguez, Sara (Centro Nacional de Investigaciones Oncológicas) ; Gago Ramos, José Luis (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Badal Lafulla, Josep (Pathology Department, Fundació Althaia, 08243 Manresa, Spain) ; Carrato, Cristina (Universitat Autònoma de Barcelona. Facultat de Medicina) ; López, Héctor (Urology Department, Fundació Althaia, 08243 Manresa, Spain) ; Quer, Ariadna (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Castellano, Daniel (Hospital Universitario 12 de Octubre (Madrid)) ; Malats, Núria (Centro de Investigación Biomédica en Red de Cáncer) ; Real, Francisco X. (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut)
Background: Platinum-based neoadjuvant chemotherapy (NAC) increases the survival of patients with organ-confined urothelial bladder cancer (UBC). In retrospective studies, patients with basal/squamous (BASQ)-like tumors present with more advanced disease and have worse prognosis. [...]
2020 - 10.3390/cancers12071784
Cancers, Vol. 12 (july 2020)  
6.
18 p, 6.6 MB A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer / López de Maturana, Evangelina (Centro de Investigación Biomédica en Red de Cáncer) ; Rodríguez, Juan Antonio (Centre de Regulació Genòmica) ; Alonso, Lola (Centro de Investigación Biomédica en Red de Cáncer) ; Lao, Oscar (Centre de Regulació Genòmica) ; Molina-Montes, Esther (Centro de Investigación Biomédica en Red de Cáncer) ; Martín-Antoniano, Isabel Adoración (Centro de Investigación Biomédica en Red de Cáncer) ; Gómez-Rubio, Paulina (Centro de Investigación Biomédica en Red de Cáncer) ; Lawlor, Rita (University and Hospital Trust of Verona. ARC-Net Centre for Applied Research on Cancer and Department of Pathology and Diagnostics) ; Carrato, Alfredo (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ; Hidalgo, Manuel (Weill Cornell Medicine) ; Iglesias, Mar (Parc de Salut MAR de Barcelona) ; Molero, Xavier (Universitat Autònoma de Barcelona. Departament de Medicina) ; Löhr, Matthias (Gastrocentrum, Karolinska Institutet and University Hospital) ; Michalski, Christopher (Martin-Luther-University Halle-WittenberHalle (Saale). Department of Visceral, Vascular and Endocrine Surgery) ; Perea, José (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; O'Rorke, Michael (The University of Iowa. College of Public Health) ; Barberà, Victor Manuel (Hospital General Universitario de Elche) ; Tardón, Adonina (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ; Farré, Antoni (Institut d'Investigació Biomèdica Sant Pau) ; Muñoz-Bellvís, Luís (Instituto de Investigación Biomédica de Salamanca) ; Crnogorac-Jurcevic, Tanja (Queen Mary University of London. Barts Cancer Institute, Centre for Molecular Oncology) ; Domínguez-Muñoz, Enrique (Complejo Hospitalario Universitario de Santiago de Compostela) ; Gress, Thomas (University Hospital of Giessen and Marburg (Alemanya)) ; Greenhalf, William (University of Liverpool. Department of Molecular and Clinical Cancer Medicine) ; Sharp, Linda (Newcastle University, Institute of Health & Society) ; Arnes, Luís (Columbia University Medical Center. Department of Systems Biology) ; Cecchini, Lluís (Parc de Salut MAR de Barcelona) ; Balsells, Joaquim (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Costello, Eithne (University of Liverpool. Department of Molecular and Clinical Cancer Medicine) ; Ilzarbe, Lucas (Parc de Salut MAR de Barcelona) ; Kleeff, Jörg (Martin-Luther-University Halle-WittenberHalle (Saale). Department of Visceral, Vascular and Endocrine Surgery) ; Kong, Bo (Technical University of Munich. Department of Surgery) ; Márquez, Mirari (Centro de Investigación Biomédica en Red de Cáncer) ; Mora Brugués, Josefina (Institut d'Investigació Biomèdica Sant Pau) ; O'Driscoll, Damian (University College Cork. National Cancer Registry Ireland and HRB Clinical Research Facility) ; Scarpa, Aldo (University and Hospital Trust of Verona. ARC-Net Centre for Applied Research on Cancer and Department of Pathology and Diagnostics) ; Ye, Weimin (Karolinska Institutet (Estocolm, Suècia). Department of Medical Epidemiology and Biostatistics) ; Yu, Jingru (Karolinska Institutet (Estocolm, Suècia). Department of Medical Epidemiology and Biostatistics) ; García-Closas, Montserrat (Centro Nacional de Investigaciones Oncológicas) ; Kogevinas, M.. (Hospital del Mar (Barcelona, Catalunya)) ; Rothman, Nathaniel (Centro Nacional de Investigaciones Oncológicas) ; Silverman, Debra T. (Centro Nacional de Investigaciones Oncológicas) ; Albanes, Demetrius (Centro Nacional de Investigaciones Oncológicas) ; Arslan, Alan A. (New York University School of Medicine. Department of Population Health) ; Beane-Freeman, Laura (Centro Nacional de Investigaciones Oncológicas) ; Bracci, Paige M. (University of California. Department of Epidemiology and Biostatistics) ; Brennan, Paul (International Agency for Research on Cancer (IARC)) ; Bueno-de-Mesquita, Bas (National Institute for Public Health and the Environment (RIVM). Deparment for Determinants of Chronic Diseases (DCD)) ; Buring, Julie (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ; Canzian, Federico (German Cancer Research Center (DKFZ. Genomic Epidemiology Group) ; Du, Margaret (Memorial Sloan Kettering Cancer Center) ; Gallinger, Steven (Sinai Health System. Prosserman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute) ; Gaziano, J. Michael (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ; Goodman, Phyllis J. (SWOG Statistical Center, Fred Hutchinson Cancer Research Center) ; Gunter, Marc (International Agency for Research on Cancer (IARC)) ; LeMarchand, Loic (University of Hawaii Cancer Center. Cancer Epidemiology Program) ; Li, Donghui (University of Texas MD Anderson Cancer Center) ; Neale, Rachael E. (QIMR Berghofer Medical Research Institute (Brisbane, Austràlia). Population Health Department) ; Peters, Ulrika (Fred Hutchinson Cancer Research Center. Division of Public Health Sciences) ; Petersen, Gloria M. (Mayo Clinic College of Medicine. Department of Health Sciences Research) ; Risch, Harvey A. (Yale School of Public Health. Department of Chronic Disease Epidemiology) ; Sánchez, Maria José (Universidad de Granada) ; Shu, Xiao-Ou (Vanderbilt University School of Medicine. Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center) ; Thornquist, Mark D. (Fred Hutchinson Cancer Research Center. Division of Public Health Sciences) ; Visvanathan, Kala (Mayo Clinic College of Medicine. Department of Health Sciences Research) ; Zheng, Wei (Vanderbilt University School of Medicine. Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center) ; Chanock, Stephen (Centro Nacional de Investigaciones Oncológicas) ; Easton, Douglas F (University of Cambridge. Centre for Cancer Genetic Epidemiology) ; Wolpin, Brian M. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Stolzenberg-Solomon, Rachael Z. (Centro Nacional de Investigaciones Oncológicas) ; Klein, Alison P. (Johns Hopkins School of Medicine. Department of Oncology, Sidney Kimmel Comprehensive Cancer Center) ; Amundadottir, Laufey T. (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Marti-Renom, Marc A. (Universitat Pompeu Fabra. Centre de Regulació Genòmica (CRG-UPF)) ; Real, Francisco X (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ; Malats, Núria (Centro de Investigación Biomédica en Red de Cáncer)
Pancreatic cancer (PC) is a complex disease in which both non-genetic and genetic factors interplay. To date, 40 GWAS hits have been associated with PC risk in individuals of European descent, explaining 4. [...]
2021 - 10.1186/s13073-020-00816-4
Genome Medicine, Vol. 13 (february 2021)  
7.
16 p, 3.1 MB Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21 / Zhang, Mingfeng (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Wang, Zhaoming (St. Jude Children's Research Hospital (Memphis, Estats Units d'Amèrica)) ; Obazee, Ofure (German Cancer Research Center (DKFZ)) ; Jia, Jinping (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Childs, Erica J. (Johns Hopkins School of Medicine. Department of Oncology) ; Hoskins, Jason (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Figlioli, Gisella (German Cancer Research Center (DKFZ)) ; Mocci, Evelina (Johns Hopkins School of Medicine. Department of Oncology) ; Collins, Irene (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Chung, Charles C. (Frederick National Laboratory for Cancer Research (Frederick, Estats Units d'Amèrica)) ; Hautman, Christopher (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Arslan, Alan A. (New York University Cancer Institute, New York, New York, USA) ; Beane-Freeman, Laura (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Bracci, Paige M. (University of California San Francisco. Department of Epidemiology and Biostatistics) ; Buring, Julie (Harvard Medical School) ; Duell, Eric J. (Institut d'Investigació Biomèdica de Bellvitge) ; Gallinger, Steven (Mount Sinai Hospital (Toronto, Canadà)) ; Giles, Graham G. (Monash University (Melbourne, Austràlia). Department of Epidemiology and Preventive Medicine) ; Goodman, Gary E. (Fred Hutchinson Cancer Research Center (Seattle, Estats Units d'Amèrica)) ; Goodman, Phyllis J. (Fred Hutchinson Cancer Research Center (Seattle, Estats Units d'Amèrica)) ; Kamineni, Aruna (Group Health Research Institute, Seattle, Washington, USA) ; Kolonel, Laurence N. (University of Hawaii Cancer Center. Cancer Epidemiology Program) ; Kulke, Matthew H. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Medical Oncology) ; Malats, Núria (Centro Nacional de Investigaciones Oncológicas) ; Olson, Sara H. (Memorial Sloan Kettering Cancer Center) ; Sesso, Howard D. (Harvard Medical School) ; Visvanathan, Kala (Johns Hopkins Bloomberg School of Public Health) ; White, Emily (University of Washington. Department of Epidemiology) ; Zheng, Wei (Vanderbilt University Medical Center (Nashville, Estats Units d'Amèrica)) ; Abnet, Christian C. (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Albanes, Demetrius (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Andreotti, Gabriella (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Brais, Lauren (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Medical Oncology) ; Bueno-de-Mesquita, H. Bas (University of Malaya (Kuala Lumpur, Malàisia). Department of Social & Preventive Medicine) ; Basso, Daniela (University Hospital of Padova (Pàdua, Itàlia)) ; Berndt, Sonja (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Boutron-Ruault, Marie-Christine (IGR, F-94805, Villejuif, France) ; Bijlsma, Maarten F. (University of Amsterdam. Laboratory for Experimental Oncology and Radiobiology) ; Brenner, Hermann (German Cancer Research Center (DKFZ)) ; Burdette, Laurie (Frederick National Laboratory for Cancer Research (Frederick, Estats Units d'Amèrica)) ; Campa, Daniele (University of Pisa (Itàlia). Department of Biology) ; Caporaso, Neil E. (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Capurso, Gabriele ('Sapienza' University of Rome. Digestive and Liver Disease Unit) ; Cavestro, Giulia Martina (Gastroenterology and Gastrointestinal Endoscopy Unit, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy) ; Cotterchio, Michelle (University of Toronto. Dalla Lana School of Public Health) ; Costello, Eithne (University of Liverpool. Liverpool Pancreas Biomedical Research Unit) ; Elena, Joanne (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Boggi, Ugo (University Hospital of Pisa (Pisa, Itàlia)) ; Gaziano, J. Michael (Massachusetts Veteran's Epidemiology, Research, and Information Center, Geriatric Research Education and Clinical Center, Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA) ; Gazouli, Maria (Department of Basic Medical Sciences, Laboratory of Biology, Medical School, National and Kapodistrian University of Athens, Athens, Greece) ; Giovannucci, Edward L. (Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA) ; Goggins, Michael (Johns Hopkins University. Department of Oncology) ; Gross, Myron (Laboratory of Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA) ; Haiman, Christopher A. (Preventive Medicine, University of Southern California, Los Angeles, California, USA) ; Hassan, Manal (Department of Gastrointestinal Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA) ; Helzlsouer, Kathy J. (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Hu, Nan (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Hunter, David J. (Harvard Medical School, Boston, Massachusetts, USA) ; Iskierka-Jazdzewska, Elzbieta (Department of Hematology, Medical University of Łodz, Łodz, Poland) ; Jenab, Mazda (International Agency for Research on Cancer (IARC), Lyon, France) ; Kaaks, Rudolf (German Cancer Research Center (DKFZ)) ; Key, Timothy J. (Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom) ; Khaw, Kay-Tee (School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom) ; Klein, Eric A. (Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA) ; Kogevinas, M.. (Institut Hospital del Mar d'Investigacions Mèdiques) ; Krogh, Vittorio (Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy) ; Kupcinskas, Juozas (Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania) ; Kurtz, Robert C. (Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA) ; Landi, Maria T. (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Landi, Stefano (Department of Biology, University of Pisa, Pisa, Italy) ; Marchand, Le Loic (Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA) ; Mambrini, Andrea (Oncology Department, ASL1 Massa Carrara, Massa Carrara, Italy) ; Mannisto, Satu (National Institute for Health and Welfare, Department of Chronic Disease Prevention, Helsinki, Finland) ; Milne, Roger L. (Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia) ; Neale, Rachel E. (QIMR Berghofer Medical Research Institute (Brisbane, Austràlia)) ; Oberg, Ann L. (Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA) ; Panico, Salvatore (Dipartimento di Medicina Clinica E Chirurgia, Federico II Univeristy, Naples, Italy) ; Patel, Alpa V. (Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA) ; Peeters, Petra H. M. (Imperial College London. Department of Epidemiology and Biostatistics) ; Peters, Ulrike (Department of Epidemiology, University of Washington, Seattle, Washington, USA) ; Pezzilli, Raffaele (Pancreas Unit, Department of Digestive Diseases and Internal Medicine, Sant'Orsola-Malpighi Hospital, Bologna, Italy) ; Porta, Miquel 1957- (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ; Purdue, Mark (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Quiros, J. Ramón (Public Health and Participation Directorate, Asturias, Spain) ; Riboli, Elio (Imperial College London. Department of Epidemiology and Biostatistics) ; Rothman, Nathaniel (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Scarpa, Aldo (University and Hospital Trust of Verona. ARC-Net Centre for Applied Research on Cancer) ; Scelo, Ghislaine (International Agency for Research on Cancer (IARC), Lyon, France) ; Shu, Xiao-Ou (Vanderbilt Epidemiology Center (Nashville, Estats Units d'Amèrica)) ; Silverman, Debra T. (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Soucek, Pavel (Laboratory of Pharmacogenomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic) ; Strobel, Oliver (Heidelberg University Hospital (Alemanya)) ; Sund, Malin (Umeå University. Department of Surgical and Perioperative Sciences) ; Małecka-Panas, Ewa (Medical University of Łodz (Polònia)) ; Taylor, Philip R. (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Tavano, Francesca (Istituto di Ricovero e Cura A Carattere Scientifico (IRCCS)) ; Travis, Ruth C. (University of Oxford. Cancer Epidemiology Unit) ; Thornquist, Mark (Fred Hutchinson Cancer Research Center (Seattle, Estats Units d'Amèrica)) ; Tjønneland, Anne (Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark) ; Tobias, Geoffrey S. (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Trichopoulos, Dimitrios (Hellenic Health Foundation, Athens, Greece) ; Vashist, Yogesh (University Hamburg-Eppendorf) ; Vodicka, Pavel (Academy of Sciences of the Czech Republic) ; Wactawski-Wende, Jean (University at Buffalo. Department of Social and Preventive Medicine) ; Wentzensen, Nicolas (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Yu, Herbert (University of Hawaii Cancer Center) ; Yu, Kai (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Zeleniuch-Jacquotte, Anne (New York University Cancer Institute) ; Kooperberg, Charles (Fred Hutchinson Cancer Research Center (Seattle, Estats Units d'Amèrica)) ; Risch, Harvey A. (Yale School of Public Health) ; Jacobs, Eric J. (American Cancer Society (Atlanta, Estats Units d'Amèrica)) ; Li, Donghui (University of Texas M.D. Anderson Cancer Center) ; Fuchs, Charles (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ; Hoover, Robert (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Hartge, Patricia (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Chanock, Stephen (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Petersen, Gloria M. (Mayo Clinic (Rochester, Estats Units d'Amèrica)) ; Stolzenberg-Solomon, Rachael S. (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ; Wolpin, Brian M. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Medical Oncology) ; Kraft, Peter (Harvard School of Public Health (Boston, Estats Units d'Amèrica)) ; Klein, Alison P. (Bloomberg School of Public Health. Department of Epidemiology) ; Canzian, Federico (German Cancer Research Center (DKFZ)) ; Amundadottir, Laufey T. (National Cancer Institute (Bethesda, Estats Units d'Amèrica))
Genome-wide association studies (GWAS) have identified common pancreatic cancer susceptibility variants at 13 chromosomal loci in individuals of European descent. To identify new susceptibility variants, we performed imputation based on 1000 Genomes (1000G) Project data and association analysis using 5,107 case and 8,845 control subjects from 27 cohort and case-control studies that participated in the PanScan I-III GWAS. [...]
2016 - 10.18632/oncotarget.11041
Oncotarget, Vol. 7 (august 2016) , p. 66328-66343  
8.
9 p, 421.4 KB An Epistatic Interaction between the PAX8 and STK17B Genes in Papillary Thyroid Cancer Susceptibility / Landa, Iñigo (Centro Nacional de Investigaciones Oncológicas) ; Boullosa, Cesar (Centro Nacional de Investigaciones Oncológicas) ; Inglada Pérez, Lucia (Centro Nacional de Investigaciones Oncológicas) ; Sastre Perona, Ana (Universidad Autónoma de Madrid. Instituto de Investigaciones Biomédicas "Alberto Sols") ; Pastor Benito, Susana (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Velázquez, Antonia (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ; Mancikova, Veronika (Centro Nacional de Investigaciones Oncológicas) ; Ruiz Llorente, Sergio (Universidad Autónoma de Madrid. Instituto de Investigaciones Biomédicas "Alberto Sols") ; Schiavi, Francesca (Institut d'Oncologia Vèneto. Clínica de Càncer Familiar i Oncoendocrinologia) ; Marcos Dauder, Ricardo (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Malats, Núria (Centro Nacional de Investigaciones Oncológicas) ; Opocher, Giuseppe (Veneto Institute of Oncology (Pàdua, Itàlia)) ; Diaz Uriarte, Ramón (Universidad Autónoma de Madrid. Instituto de Investigaciones Biomédicas "Alberto Sols") ; Santisteban, Pilar (Universidad Autónoma de Madrid. Instituto de Investigaciones Biomédicas "Alberto Sols") ; Valencia, Alfonso (Centro Nacional de Investigaciones Oncológicas) ; Robledo, Mercedes (Centro Nacional de Investigaciones Oncológicas)
Papillary Thyroid Cancer (PTC) is a heterogeneous and complex disease; susceptibility to PTC is influenced by the joint effects of multiple common, low-penetrance genes, although relatively few have been identified to date. [...]
2013 - 10.1371/journal.pone.0074765
PloS one, Vol. 8 Issue 9 (September 2013) , p. e74765  

Documentos de investigación Encontrados 2 registros  
1.
61 p, 377.7 KB Cáncer de páncreas y cáncer del sistema biliar : validez del diagnóstico y de las fuentes de información : estudio de dieta, alcohol y café como factores de riesgo del cáncer de páncreas / Soler Cera, Maria ; Porta, Miquel, 1957- , dir. (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ; Malats, Núria, dir. (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública)
Los resultados contradictorios entre estudios etiológicos es frecuente ya que: (1) existen dificultades diagnósticas en el CPE y CSBE. (2) La definición de los factores de riesgo es variable. (3) Se usan fuentes de información diferentes para obtener la información sobre exposición. [...]
Epidemiologic studies on exocrine pancreatic cancer show a large heterogeneity in results for some situations: (1) because diagnostic criteria are different in all studies (2) because data accuracy may be one of the factors that could affect study validity and (3) because every study have a different source of information. [...]

Bellaterra : Universitat Autònoma de Barcelona, 2003
2 documentos
2.
237 p, 3.6 MB Variabilitat en el maneig diagnòstic, terapèutic i pronòstic del càncer de bufeta urinària a l'estat espanyol : anàlisi de cinc àrees geogràfiques i per categoria d'hospital / Cecchini, Lluís ; Malats, Núria, dir. (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Gelabert Mas, Antonio, dir. (Universitat Autònoma de Barcelona. Departament de Cirurgia)
Introducció: El càncer de bufeta urinària és una patologia amb una alta incidència en el nostre país i que, en una gran part dels casos, esdevé una malaltia crònica, amb la càrrega que això suposa pels pacients i pel sistema sanitari. [...]
Introduction: Bladder cancer is a high incidence pathology in our country, becoming in a wide majority of cases a chronic disease, which turns it into a heavy load both to patients and to the health system. [...]

Bellaterra : Universitat Autònoma de Barcelona, 2007  

Materiales académicos Encontrados 1 registros  
1.
5 p, 826.2 KB Salut ambiental [23834] / Kogevinas, Manolis ; Sala, Maria ; Antó i Boqué, Josep Maria ; Porta, Miquel, 1957- ; Malats, Núria ; Soriano, Joan ; Sunyer, Jordi ; Universitat Autònoma de Barcelona. Facultat de Ciències
1995-96
Llicenciat en Ciències Ambientals [113]  

Vea también: autores con nombres similares
6 Malats, N.
14 Malats, Nuria
2 Malats, Núria,
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.